'Turmoil' at key Trump agency could cause problems for GOP in midterms: report

Donald Trump's administration has fallen short of easing tensions with the drug industry after talks were held yesterday (February 17).

Pricing for initiatives that may benefit the pharmaceutical trade and inconsistent standards from the Food and Drug Administration have stoked anxiety within the industry, according to insiders. An industry forum led to minimal success for both the wants of the drug industry and the Trump administration.

Centers for Medicare and Medicaid Services...